Dana-Farber Cancer Institute Financial Analyst Salaries in Boston | Comparably
Dana-Farber Cancer Institute is a center dedicated to carrying out adult and pediatric cancer treatment activities and advanced research. read more
EMPLOYEE
PARTICIPANTS
28
TOTAL
RATINGS
198

Dana-Farber Cancer Institute Financial Analyst Salaries in Boston

The average Dana-Farber Cancer Institute Financial Analyst in Boston earns $62,004 annually. This total compensation is $25,396 less than the US average for a Financial Analyst.

In Boston, The Finance Department at Dana-Farber Cancer Institute earns $4,083 more on average than the Customer Support Department.

Last updated 7 months ago.

$22k
$41k
$62k
$82k
$180k
$310k
$375k
$62,004
Average Compensation
$62,004
avg. base

Financial Analyst Salaries at Dana-Farber Cancer Institute

In Boston, Financial Analysts earn $5,861 less than Accountants.

Accounting Manager
$118k*
Senior Accountant
$84k*
Business Analyst
$71k*
Accountant
$68k*
Financial Analyst
$62k
* estimated salary

Compensation at Dana-Farber Cancer Institute by Department

In Boston, The Finance Department averages $4,083 more than the Customer Support Department, and $5,506 less than the Business Development Department

Business Development
$77,649 Avg. total comp.
+$6k
Finance
$72,143 Avg. total comp.
Customer Support
$68,060 Avg. total comp.
-$4k

Financial Analyst Compensation by Gender (All Companies)

The average female Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $89,840, while the average male Financial Analyst at similar sized companies reported making $94,632.

Financial Analyst Compensation by Ethnicity (All Companies)

The average Asian or Pacific Islander Financial Analyst at companies similar size to Dana-Farber Cancer Institute reported making $97,825, while the average African American/Black Financial Analyst at similar sized companies reported making $68,750.

How Financial Analysts at Dana-Farber Cancer Institute Rate Their Compensation

The majority of Financial Analysts at Dana-Farber Cancer Institute believe they're compensated fairly. The vast majority (78%) of Financial Analysts at Dana-Farber Cancer Institute are satisfied with their benefits. See more compensation ratings at Dana-Farber Cancer Institute

×
Rate your company